Hannah Hazard-Jenkins named director of WVU Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Hannah Hazard-Jenkins, associate chair of surgery for cancer services, was named the permanent director of the WVU Cancer Institute after having served in the position on an interim basis since January.

“I have been and will always be committed to ensuring that everyone who seeks us out for care has access to the latest advancements in treatment, procedures, and clinical trials regardless of where they come into our system—whether it’s at our flagship campus in Morgantown or one of our regional sites,” Hazard-Jenkins said in a statement.

As the director of clinical services for the WVU Cancer Institute’s Mary Babb Randolph Cancer Center, Hazard-Jenkins helped manage clinical affairs and programmatic development, as well as the institute’s statewide network of cancer care. She also serves as the director of the institute’s Comprehensive Breast Cancer Program and as chief of staff at WVU Medicine J.W. Ruby Memorial Hospital.

Table of Contents

YOU MAY BE INTERESTED IN

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login